Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Avodart


Contraindicated
Risk of inhibition of the development of the external genitalia of the foetus

Contraindicated
Manque de données
Avodart :
Type Medicine Authorised
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory GSK
Manufacturer Pharmaline SAL*
Manufacturing Type Licensed by Glaxo SmithKline Export Ltd , UK
Origin Lebanon
ATC G04CB02

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date : 23/10/2013


Avodart  MoH 10181 :
Form Capsule, soft
Packaging Blisters
Package Size Box of 30
Strength 0.5mg
Public Price 2615688,08 L.L.
Stratum B
NSSF
Quarantine
Reg. Number 168319/1
Submission date 2020
Registration Year 03/08/2020




NB : Reregistration in 2020 with Different manufacturer


Price Comparison

Country: Lebanon
Form: Capsule, soft
Package Size: Box of 30
Public Price: 2615688.08 LBP ( 2,615,688.08 LBP )
Pack size unit used: 30
Cost/Unit: 87189,6 LBP ( 87,189.00 LBP )
Pricing Date: 10/01/2024

Country: Iceland
Package Size: 30
Public Price: 6329 ISK ( 701,632.94 LBP )
Pack size unit used: 30
Cost/Unit: 210,9667 ISK ( 23,280.60 LBP )
Pharmacy Price: 3536 ISK ( 392000.96 LBP )
Reference: Icelandic Medicines Agency
Pricing Date: 01/04/2020
Type: Medicine Authorised

Country: Qatar
Package Size: 30
Public Price: 152 QAR ( 630,885.12 LBP )
Pack size unit used: 30
Cost/Unit: 5,0667 QAR ( 20,752.80 LBP )
Pharmacy Price: 125 QAR ( 518820 LBP )
Pricing Date: 28/01/2021
Type: Medicine Authorised

Country: Abu Dhabi
Package Size: 30
Public Price: 150.5 AED ( 618,699.48 LBP )
Pack size unit used: 30
Cost/Unit: 5,0167 AED ( 20,554.80 LBP )
Pharmacy Price: 121.13 AED ( 497960.5848 LBP )
Pricing Date: 27/01/2021
Type: Medicine Authorised

Country: UAE
Package Size: 30's (10's Blister x 3)
Public Price: 150.5 AED ( 618,699.48 LBP )
Pack size unit used: 30
Cost/Unit: 5,0167 AED ( 20,554.80 LBP )
Pharmacy Price: 121.13 AED ( 497960.5848 LBP )
Pricing Date: 21/08/2019
Type: Medicine Authorised

Country: Germany
Package Size: 30
Public Price: 50.87 EUR ( 934,993.14 LBP )
Pack size unit used: 30
Cost/Unit: 1,6957 EUR ( 18,380.05 LBP )
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: Belgium
Package Size: 30
Public Price: 44.83 EUR ( 823,977.64 LBP )
Pack size unit used: 30
Cost/Unit: 1,4943 EUR ( 18,380.05 LBP )
Reference: cbip
Pricing Date: 27/11/2020
Type: Medicine Authorised

Country: Norway
Package Size: 30
Public Price: 314.3 NOK ( 543,823.86 LBP )
Pack size unit used: 30
Cost/Unit: 10,4767 NOK ( 17,302.70 LBP )
Pharmacy Price: 218.08 NOK ( 377337.2816 LBP )
Reference: Norwegian Medicine Agency
Pricing Date: 01/04/2020
Type: Medicine Withdrawn

Country: Switzerland
Package Size: 30
Public Price: 41.65 CHF ( 710,559.41 LBP )
Pack size unit used: 30
Cost/Unit: 1,3883 CHF ( 17,060.25 LBP )
Exfactory Price: 22.01 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: KSA
Package Size: 30
Public Price: 139.85 SAR ( 563,648.64 LBP )
Pack size unit used: 30
Cost/Unit: 4,6617 SAR ( 16,121.52 LBP )
Reference: sfda
Pricing Date: 16/01/2021
Type: Medicine Authorised

Country: Czech Republic
Package Size: 90
Public Price: 2062.16 CZK ( 1,424,457.64 LBP )
Pack size unit used: 90
Cost/Unit: 22,9129 CZK ( 15,196.72 LBP )
Reference: SUKL
Pricing Date: 28/02/2020
Type: Medicine Authorised

Country: Egypt
Package Size: 30
Public Price: 160 EGP ( 153,616.00 LBP )
Pack size unit used: 30
Cost/Unit: 5,3333 EGP ( 4,800.50 LBP )
Pricing Date: 20/11/2019
Type: Medicine Authorised

Country: Turkey
Package Size: 30
Public Price: 39.77 TRY ( 76,385.84 LBP )
Pack size unit used: 30
Cost/Unit: 1,3257 TRY ( 1,920.69 LBP )
Pricing Date: 28/10/2020
Type: Medicine Authorised

Country: Bahrain
Package Size: 30
Public Price: 14.61 BHD ( 586,164.45 LBP )
Pack size unit used: 30
Cost/Unit: 0,487 BHD ( 0.00 LBP )
Reference: nhra
Pricing Date: 09/02/2021
Type: Medicine Authorised

Country: Spain
Package Size: 30
Public Price: 20.11 EUR ( 369,622.81 LBP )
Pack size unit used: 30
Cost/Unit: 0,6703 EUR ( 0.00 LBP )
Pharmacy Price: 12.88 EUR ( 236735.044 LBP )
Reference: Agencia Española de Medicamentos y Productos Sanitarios
Pricing Date: 06/05/2021
Type: Medicine Authorised

Country: Kuweit
Package Size: Boîte de 30
Public Price: 12.48 KWD ( 618,634.60 LBP )
Pack size unit used: 30
Cost/Unit: 0,416 KWD ( 0.00 LBP )
Pharmacy Price: 10.55 KWD ( 522964.344 LBP )
Pricing Date: 07/02/2021
Type: Medicine Authorised

Country: The Netherlands
Package Size: 30
Public Price: 24.63 EUR ( 452,700.63 LBP )
Pack size unit used: 30
Cost/Unit: 0,821 EUR ( 0.00 LBP )
Pharmacy Price: 17.63 EUR ( 324040.2815 LBP )
Reference: Zorginstituut Nederland
Pricing Date: 15/06/2019
Type: Medicine Authorised

Country: Greece
Package Size: 30
Public Price: 9.38 EUR ( 172,404.87 LBP )
Pack size unit used: 30
Cost/Unit: 0,3127 EUR ( 0.00 LBP )
Exfactory Price: 6.49 EUR
Pharmacy Price: 6.81 EUR ( 125168.1405 LBP )
Reference: National Organization for Medicines
Pricing Date: 25/02/2021
Type: Medicine Authorised

Country: Finland
Package Size: 30
Public Price: 6.17 EUR ( 113,404.91 LBP )
Pack size unit used: 30
Cost/Unit: 0,2057 EUR ( 0.00 LBP )
Reference: Kela
Pricing Date: 22/04/2021
Type: Medicine Authorised

Country: Italy
Package Size: 30UNITA
Public Price: 11.78 EUR ( 216,516.99 LBP )
Pack size unit used: 30
Cost/Unit: 0,3927 EUR ( 0.00 LBP )
Pricing Date: 15/01/2021
Type: Medicine Authorised

Country: Ireland
Package Size: 30
Public Price: 16.04 EUR ( 294,816.00 LBP )
Pack size unit used: 30
Cost/Unit: 0,5347 EUR ( 0.00 LBP )
Exfactory Price: 23 EUR
Pricing Date: 09/10/2020
Type: Medicine Authorised

Country: France
Package Size: 30
Public Price: 17.6 EUR ( 323,488.88 LBP )
Pack size unit used: 30
Cost/Unit: 0,5867 EUR ( 0.00 LBP )
Reference: ansm
Pricing Date: 15/05/2021
Type: Medicine Authorised

Country: Cyprus
Package Size: 30
Public Price: 19.55 EUR ( 359,329.98 LBP )
Pack size unit used: 30
Cost/Unit: 0,6517 EUR ( 0.00 LBP )
Reference: Cyprus Minister of Health
Pricing Date: 24/03/2021
Type: Medicine Authorised

Country: Portugal
Package Size: 30
Public Price: 21.76 EUR ( 399,949.89 LBP )
Pack size unit used: 30
Cost/Unit: 0,7253 EUR ( 0.00 LBP )
Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
Pricing Date: 22/04/2019
Type: Medicine Authorised

Country: Oman
Package Size: 30
Public Price: 16.02 OMR ( 629,594.01 LBP )
Pack size unit used: 30
Cost/Unit: 0,534 OMR ( 0.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Jordan
Package Size: 30
Public Price: 18.81 JOD ( 401,408.97 LBP )
Pack size unit used: 30
Cost/Unit: 0,627 JOD ( 0.00 LBP )
Pharmacy Price: 14.36 JOD ( 306445.1284 LBP )
Reference: JFDA
Pricing Date: 02/01/2021
Type: Medicine Authorised

Country: UK
Package Size: 30
Public Price: 14.6 GBP ( 294,201.24 LBP )
Pack size unit used: 30
Cost/Unit: 0,4867 GBP ( 0.00 LBP )
Reference: DMD
Pricing Date: 08/03/2021
Type: Medicine Authorised

Country: Tunisia
Package Size: Boîte de 30
Public Price: 55.99 TND ( 0.00 LBP )
Pack size unit used: 30
Cost/Unit: 1,8663 TND ( 0.00 LBP )
Pricing Date: 04/02/2019
Type: Medicine Authorised

Country: Denmark
Package Size: 30
Reference: Danish Medicine Agency
Pricing Date: 19/05/2021
Type: Medicine Non Marketed

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries


Note

Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 87189,6 LBP ( 87,189.00 LBP )
Cost/Day: 87189,6 LBP ( 87,189.00 LBP )
Cost/Month: 2615688 LBP ( 2,615,688.00 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 87189,6 LBP ( 87,189.00 LBP )
Cost/Day: 87189,6 LBP ( 87,189.00 LBP )
Cost/Month: 2615688 LBP ( 2,615,688.00 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 210,9667 ISK ( 23,280.60 LBP )
Cost/Day: 210,97 ISK ( 23,280.60 LBP )
Cost/Month: 6329,1 ISK ( 701,632.94 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 210,9667 ISK ( 23,280.60 LBP )
Cost/Day: 210,97 ISK ( 23,280.60 LBP )
Cost/Month: 6329,1 ISK ( 701,632.94 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 5,0667 QAR ( 20,752.80 LBP )
Cost/Day: 5,07 QAR ( 20,752.80 LBP )
Cost/Month: 152,1 QAR ( 630,885.12 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 5,0667 QAR ( 20,752.80 LBP )
Cost/Day: 5,07 QAR ( 20,752.80 LBP )
Cost/Month: 152,1 QAR ( 630,885.12 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 5,0167 AED ( 20,554.80 LBP )
Cost/Day: 5,02 AED ( 20,554.80 LBP )
Cost/Month: 150,6 AED ( 616,644.00 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 5,0167 AED ( 20,554.80 LBP )
Cost/Day: 5,02 AED ( 20,554.80 LBP )
Cost/Month: 150,6 AED ( 616,644.00 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 5,0167 AED ( 20,554.80 LBP )
Cost/Day: 5,02 AED ( 20,554.80 LBP )
Cost/Month: 150,6 AED ( 616,644.00 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 5,0167 AED ( 20,554.80 LBP )
Cost/Day: 5,02 AED ( 20,554.80 LBP )
Cost/Month: 150,6 AED ( 616,644.00 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 1,6957 EUR ( 18,380.05 LBP )
Cost/Day: 1,7 EUR ( 18,380.05 LBP )
Cost/Month: 51 EUR ( 937,382.55 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 1,6957 EUR ( 18,380.05 LBP )
Cost/Day: 1,7 EUR ( 18,380.05 LBP )
Cost/Month: 51 EUR ( 937,382.55 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 1,4943 EUR ( 18,380.05 LBP )
Cost/Day: 1,49 EUR ( 18,380.05 LBP )
Cost/Month: 44,7 EUR ( 808,722.20 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 1,4943 EUR ( 18,380.05 LBP )
Cost/Day: 1,49 EUR ( 18,380.05 LBP )
Cost/Month: 44,7 EUR ( 808,722.20 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 10,4767 NOK ( 17,302.70 LBP )
Cost/Day: 10,48 NOK ( 17,302.70 LBP )
Cost/Month: 314,4 NOK ( 543,304.78 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 10,4767 NOK ( 17,302.70 LBP )
Cost/Day: 10,48 NOK ( 17,302.70 LBP )
Cost/Month: 314,4 NOK ( 543,304.78 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 1,3883 CHF ( 17,060.25 LBP )
Cost/Day: 1,39 CHF ( 17,060.25 LBP )
Cost/Month: 41,7 CHF ( 699,470.25 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 1,3883 CHF ( 17,060.25 LBP )
Cost/Day: 1,39 CHF ( 17,060.25 LBP )
Cost/Month: 41,7 CHF ( 699,470.25 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 4,6617 SAR ( 16,121.52 LBP )
Cost/Day: 4,66 SAR ( 16,121.52 LBP )
Cost/Month: 139,8 SAR ( 560,222.82 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 4,6617 SAR ( 16,121.52 LBP )
Cost/Day: 4,66 SAR ( 16,121.52 LBP )
Cost/Month: 139,8 SAR ( 560,222.82 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 22,9129 CZK ( 15,196.72 LBP )
Cost/Day: 22,91 CZK ( 15,196.72 LBP )
Cost/Month: 687,3 CZK ( 474,552.12 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 22,9129 CZK ( 15,196.72 LBP )
Cost/Day: 22,91 CZK ( 15,196.72 LBP )
Cost/Month: 687,3 CZK ( 474,552.12 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 5,3333 EGP ( 4,800.50 LBP )
Cost/Day: 5,33 EGP ( 4,800.50 LBP )
Cost/Month: 159,9 EGP ( 152,655.90 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 5,3333 EGP ( 4,800.50 LBP )
Cost/Day: 5,33 EGP ( 4,800.50 LBP )
Cost/Month: 159,9 EGP ( 152,655.90 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 1,3257 TRY ( 1,920.69 LBP )
Cost/Day: 1,33 TRY ( 1,920.69 LBP )
Cost/Month: 39,9 TRY ( 74,906.91 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 1,3257 TRY ( 1,920.69 LBP )
Cost/Day: 1,33 TRY ( 1,920.69 LBP )
Cost/Month: 39,9 TRY ( 74,906.91 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,5347 EUR ( 0.00 LBP )
Cost/Day: 0,53 EUR ( 0.00 LBP )
Cost/Month: 15,9 EUR ( 275,700.75 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,5347 EUR ( 0.00 LBP )
Cost/Day: 0,53 EUR ( 0.00 LBP )
Cost/Month: 15,9 EUR ( 275,700.75 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,627 JOD ( 0.00 LBP )
Cost/Day: 0,63 JOD ( 0.00 LBP )
Cost/Month: 18,9 JOD ( 384,123.42 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,627 JOD ( 0.00 LBP )
Cost/Day: 0,63 JOD ( 0.00 LBP )
Cost/Month: 18,9 JOD ( 384,123.42 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,3927 EUR ( 0.00 LBP )
Cost/Day: 0,39 EUR ( 0.00 LBP )
Cost/Month: 11,7 EUR ( 202,180.55 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,3927 EUR ( 0.00 LBP )
Cost/Day: 0,39 EUR ( 0.00 LBP )
Cost/Month: 11,7 EUR ( 202,180.55 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,534 OMR ( 0.00 LBP )
Cost/Day: 0,53 OMR ( 0.00 LBP )
Cost/Month: 15,9 OMR ( 589,507.50 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,534 OMR ( 0.00 LBP )
Cost/Day: 0,53 OMR ( 0.00 LBP )
Cost/Month: 15,9 OMR ( 589,507.50 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,2057 EUR ( 0.00 LBP )
Cost/Day: 0,21 EUR ( 0.00 LBP )
Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,2057 EUR ( 0.00 LBP )
Cost/Day: 0,21 EUR ( 0.00 LBP )
Cost/Month: 6,3 EUR ( 110,280.30 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,3127 EUR ( 0.00 LBP )
Cost/Day: 0,31 EUR ( 0.00 LBP )
Cost/Month: 9,3 EUR ( 165,420.45 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,3127 EUR ( 0.00 LBP )
Cost/Day: 0,31 EUR ( 0.00 LBP )
Cost/Month: 9,3 EUR ( 165,420.45 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,821 EUR ( 0.00 LBP )
Cost/Day: 0,82 EUR ( 0.00 LBP )
Cost/Month: 24,6 EUR ( 441,121.20 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,821 EUR ( 0.00 LBP )
Cost/Day: 0,82 EUR ( 0.00 LBP )
Cost/Month: 24,6 EUR ( 441,121.20 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,6703 EUR ( 0.00 LBP )
Cost/Day: 0,67 EUR ( 0.00 LBP )
Cost/Month: 20,1 EUR ( 367,601.00 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,6703 EUR ( 0.00 LBP )
Cost/Day: 0,67 EUR ( 0.00 LBP )
Cost/Month: 20,1 EUR ( 367,601.00 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,7253 EUR ( 0.00 LBP )
Cost/Day: 0,73 EUR ( 0.00 LBP )
Cost/Month: 21,9 EUR ( 385,981.05 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,7253 EUR ( 0.00 LBP )
Cost/Day: 0,73 EUR ( 0.00 LBP )
Cost/Month: 21,9 EUR ( 385,981.05 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,487 BHD ( 0.00 LBP )
Cost/Day: 0,49 BHD ( 0.00 LBP )
Cost/Month: 14,7 BHD ( 561,690.78 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,487 BHD ( 0.00 LBP )
Cost/Day: 0,49 BHD ( 0.00 LBP )
Cost/Month: 14,7 BHD ( 561,690.78 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,6517 EUR ( 0.00 LBP )
Cost/Day: 0,65 EUR ( 0.00 LBP )
Cost/Month: 19,5 EUR ( 349,220.95 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,6517 EUR ( 0.00 LBP )
Cost/Day: 0,65 EUR ( 0.00 LBP )
Cost/Month: 19,5 EUR ( 349,220.95 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,5867 EUR ( 0.00 LBP )
Cost/Day: 0,59 EUR ( 0.00 LBP )
Cost/Month: 17,7 EUR ( 312,460.85 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,5867 EUR ( 0.00 LBP )
Cost/Day: 0,59 EUR ( 0.00 LBP )
Cost/Month: 17,7 EUR ( 312,460.85 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,4867 GBP ( 0.00 LBP )
Cost/Day: 0,49 GBP ( 0.00 LBP )
Cost/Month: 14,7 GBP ( 282,110.78 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,4867 GBP ( 0.00 LBP )
Cost/Day: 0,49 GBP ( 0.00 LBP )
Cost/Month: 14,7 GBP ( 282,110.78 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 0,416 KWD ( 0.00 LBP )
Cost/Day: 0,42 KWD ( 0.00 LBP )
Cost/Month: 12,6 KWD ( 594,840.96 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 0,416 KWD ( 0.00 LBP )
Cost/Day: 0,42 KWD ( 0.00 LBP )
Cost/Month: 12,6 KWD ( 594,840.96 LBP )
Reduction in the risk of acute urinary retention and surgery in patients with BPH : (Adults)
Cost/Unit: 1,8663 TND ( 0.00 LBP )
Cost/Day: 1,87 TND ( 0.00 LBP )
Cost/Month: 56,1 TND ( 0.00 LBP )
Treatment of the signs and symptoms of benign prostatic hyperplasia : (Adults)
Cost/Unit: 1,8663 TND ( 0.00 LBP )
Cost/Day: 1,87 TND ( 0.00 LBP )
Cost/Month: 56,1 TND ( 0.00 LBP )

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info